[1]
Naomi Winny Tioline, S. Subagio, and Wita Zahara, “Effectiveness of Nivolumab and Pembrolizumab as PD-1 Inhibitors in Unresectable or Metastatic Advanced Melanoma: A Systematic Review”, KESANS, vol. 5, no. 10, pp. 2027–2038, Jul. 2026.